FULLERTON, Calif., Sept. 29, 2026 (GLOBE NEWSWIRE) — Liminatus Pharma, Inc. (Nasdaq: LIMN) (“Liminatus” or the “Company”) today announced that the Company has regained compliance with Nasdaq’s minimum bid price rule. As previously disclosed, on January 15, 2026 the Company received a notice from Nasdaq indicating that the closing bid price of the Company’s common stock had been below $1.00 for 30 consecutive business days, and, consequently, the Company was not in compliance with Nasdaq Listing Rule 5450(a)(1) (the applicable minimum bid price requirement for The Nasdaq Global Market). Following an appeal and hearing before the Nasdaq Hearings Panel, the Panel determined to transfer the Company to The Nasdaq Capital Market effective August 4, 2026 and granted the Company an extension to demonstrate compliance with Nasdaq Listing...

Partnership Integrates Usio’s Embedded Payment Capabilities into Harris’ Utility CIS Platform Utilities Gain Access to Modern, Flexible Payment Options Across Virtually All Payment Channels SAN ANTONIO, Texas, Sept. 29, 2026 (GLOBE NEWSWIRE) — Usio, Inc. (“Usio” or the “Company”) (Nasdaq: USIO), a leading FinTech company that operates a full stack of integrated, cloud-based electronic payment and embedded financial solutions, today announced a strategic partnership with Harris Computer Corporation (Harris), a globally recognized provider of advanced enterprise software solutions, including billing and customer information systems for the utility industry. Under the agreement, Harris has designated Usio as a ‘Preferred Payments Services Provider’ and will integrate Usio’s payment technology into...

Recognition Highlights XCOM RAN’s Role in Transforming Warehouse Connectivity, Automation and Real-Time Operations by Delivering the Essential Infrastructure for Physical AIWarehouse Technology Innovation of the YearXCOM RAN Named “Warehouse Technology Innovation of the Year” in SupplyTech Breakthrough AwardsSAN DIEGO, Sept. 29, 2026 (GLOBE NEWSWIRE) — XCOM RAN by Globalstar, a pioneer in next-generation private 5G technology, today announced it has been awarded “Warehouse Technology Innovation of the Year” in the 5th annual SupplyTech Breakthrough Awards program conducted by SupplyTech Breakthrough, a leading independent market intelligence organization that evaluates and recognizes standout technology companies, products and services in the global supply chain & logistics industry. The annual SupplyTech Breakthrough...

VEON’s Beeline Kazakhstan Becomes First Operator in Country to Launch Starlink’s Satellite to Mobile ServiceVEON’s Beeline Kazakhstan Becomes First Operator in Country to Launch Starlink’s Satellite to Mobile ServiceCustomers will be directly connected in cellular dead zones, giving a major boost to coverage Almaty, New York and Dubai [29 September 2026] — VEON Ltd. (Nasdaq: VEON), a global digital operator, today announced that customers in Kazakhstan will now be able to use Starlink Mobile on their smartphones to access apps and messaging in areas without terrestrial mobile coverage. Beeline Kazakhstan, in partnership with Starlink, the world’s largest direct-to-device satellite network, enables resilient connectivity directly to smartphones without need for a satellite phone, antenna, or any other special equipment. Service...

Ernexa selected for the Emerging Track, recognizing the Company among emerging innovators in the cell and gene therapy sector President & CEO Sanjeev Luther to deliver an Innovation Spotlight presentation on October 6, 2026, at 1:30 PM Presentation to highlight Ernexa’s focused oncology strategy, beginning with ERNA-101 in platinum-resistant ovarian cancer and its potential for broader expansion across ovarian cancer and other solid tumor indications Differentiated synthetic iMSC platform designed to provide a scalable, off-the-shelf treatment solution without the need for patient-specific cell harvesting ERNA-101 remains on track for planned IND submission in 2026 CAMBRIDGE, Mass., Sept. 29, 2026 (GLOBE NEWSWIRE) — Ernexa Therapeutics (Nasdaq: ERNA), an industry innovator developing novel cell therapies for the treatment of...

Agreement Moves Previously Announced Antidote Partnership into Paid Deployment KNOXVILLE, Tenn., Sept. 29, 2026 (GLOBE NEWSWIRE) — SafeSpace Global Corporation (OTCID: SSGC) (“SafeSpace Global” or the “Company”), a publicly traded, applied multimodal AI-powered physical safety and security technology company, today announced that it has executed a Statement of Work (“SOW”) with Antidote Health Ventures, LLC (“Antidote”) to begin the initial paid deployment of SafeSpace Global’s Behavioral Health safety platform at an Antidote facility in Tennessee. The SOW represents the next phase of the strategic relationship between SafeSpace Global and Antidote announced on June 10, 2026, when the companies entered into a Master Services Agreement (“MSA”) supporting the launch of SafeSpace Global’s Addiction Treatment Vertical. GlobeNewswire Under...

Simone Biles opens up about her experience managing the symptoms of these conditions and encourages long-term control of skin health Biles’ treatment, ZORYVE® (roflumilast), is the #1 prescribed branded topical therapy for three major inflammatory skin conditions combined — seborrheic dermatitis, eczema, and plaque psoriasisWESTLAKE VILLAGE, Calif., Sept. 29, 2026 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that World Champion gymnast Simone Biles has partnered with the company to launch its Skin to Believe In awareness campaign. The campaign encourages the approximately 36 million Americans living with inflammatory skin conditions, such as seborrheic dermatitis and atopic dermatitis...